Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant--United States, February 14-March 27, 2022

Authors :: Prasad, Namrata
Derado, Gordana
Nanduri, Srinivas Acharya
Reses, Hannah E.
Dubendris, Heather
Wong, Emily
Soe, Minn Minn
Li, Qunna
Dollard, Philip
Bagchi, Suparna
Edwards, Jonathan
Shang, Nong
Budnitz, Dan
Bell, Jeneita
Verani, Jennifer R.
Benin, Andrea
Link-Gelles, Ruth
Jernigan, John
Pilishvili, Tamara
Source :: Morbidity and Mortality Weekly Report. May 6, 2022, Vol. 71 Issue 18, p633, 5 p.
Publication Year :: 2022
Abstract: Nursing home residents have experienced disproportionally high levels of COVID-19--associated morbidity and mortality and were prioritized for early COVID-19 vaccination (1). Following reported declines in vaccine-induced immunity after primary series [...]

Subjects :: Johnson & Johnson
Pfizer Inc.
Vaccination -- Health aspects
RNA -- Health aspects
Vaccines -- Health aspects
Nursing homes -- Health aspects
Pharmaceutical industry -- Health aspects
Health

Tools